Logo image
Impact of diabetes on myocardial fibrosis in patients with hypertension: the REMODEL study
Journal article   Open access   Peer reviewed

Impact of diabetes on myocardial fibrosis in patients with hypertension: the REMODEL study

Chee Jian Pua, Germaine Loo, Michelle Kui, Wai Lun Moy, An-An Hii, Vivian Lee, Chee-Tang Chin, Jennifer A Bryant, Desiree-Faye Toh, Chi-Hang Lee, …
Circulation: Cardiovascular Imaging, Vol.16(7), pp.545-553
07/2023
Handle:
https://hdl.handle.net/10523/45082

Abstract

heart disease hypertension magnetic resonance imaging myocardial fibrosis
Background: Compared with patients with hypertension only, those with hypertension and diabetes (HTN/DM) have worse prognosis. We aimed to characterize morphological differences between hypertension and HTN/DM using cardiovascular magnetic resonance; and compare differentially expressed proteins associated with myocardial fibrosis using high throughput multiplex assays. Methods: Asymptomatic patients underwent cardiovascular magnetic resonance: 438 patients with hypertension (60±8 years; 59% males) and 167 age- and sex-matched patients with HTN/DM (60±10 years; 64% males). Replacement myocardial fibrosis was defined as nonischemic late gadolinium enhancement on cardiovascular magnetic resonance. Extracellular volume fraction was used as a marker of diffuse myocardial fibrosis. A total of 184 serum proteins (Olink Target Cardiovascular Disease II and III panels) were measured to identify unique signatures associated with myocardial fibrosis in all patients. Results: Despite similar left ventricular mass (P=0.344) and systolic blood pressure (P=0.086), patients with HTN/DM had increased concentricity and worse multidirectional strain (P<0.001 for comparison of all strain measures) compared to hypertension only. Replacement myocardial fibrosis was present in 28% of patients with HTN/DM compared to 16% of those with hypertension (P<0.001). NT-proBNP (N-terminal pro-B-type natriuretic peptide) was the only protein differentially upregulated in hypertension patients with replacement myocardial fibrosis and independently associated with extracellular volume. In patients with HTN/DM, GDF-15 (growth differentiation factor 15) was independently associated with replacement myocardial fibrosis and extracellular volume. Ingenuity Pathway Analysis demonstrated a strong association between increased inflammatory response/immune cell trafficking and myocardial fibrosis in patients with HTN/DM. Conclusions: Adverse cardiac remodeling was observed in patients with HTN/DM. The novel proteomic signatures and associated biological activities of increased immune and inflammatory response may partly explain these observations.
pdf
pua-et-al-2023-impact-of-diabetes-on-myocardial-fibrosis-in-patients-with-hypertension-the-remodel-study1.04 MBDownloadView
Published (Version of record) Open Access CC BY-NC-ND V4.0
url
https://doi.org/10.1161/CIRCIMAGING.123.015051View
Published (Version of record) Open

Metrics

66 File views/ downloads
14 Record Views

Details

Logo image